Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section

Home Videos Research Press Release Q&A Discussion

Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

2

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

1

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

3

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

3

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

1

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

1

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

3

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

over 11 years ago

1

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

1

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

4

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

1

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

3

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

0

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

over 11 years ago

1

in response to seaside's message

seaside,

Insulin, in any form, will not stress the pancreas. It is the GLP-1 analogues and DDP-4 inhibitors, which directly or indirectly stimulate the pancreas to release more insulin, that could cause pancreatic stress.

Loading...

Loading...

Please to post a reply

liahall

City

maine

Rank

President

Activity Points

1896

Rating

Your Rating

Please Log In to Vote

Date Joined

03/19/2012

Social Links

Private Message

Mannkind

Symbol

MNKD

Exchange

NAZ

Shares

Industry

Technology & Medical

Website